Saturday, November 14, 2026

Gold Bullish Momentum: 0.39% Up Since The Last Session

ViaNews Editorial Team

January 12, 2021

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Gold Bullish Momentum: 0.39% Up Since The Last Session

Gold is currently on bullish momentum. At 01:00 EST on Tuesday, 12 January, Gold is at $1,858.00 and 0.39% up since the last session's close.

Gold Range

Gold is 0.759% up from its last session low of $1,844.00 and 0.476% up from its last session high of $1,849.20.

Gold is 3.15% down from its last three sessions higher value of $1,918.40 and is 1.65% up from its last three sessions lower value of $1,827.80.

Gold is 5.16% down from its last seven sessions higher value of $1,959.00 and is 1.65% up from its last seven sessions lower value of $1,827.80.

Gold is 5.16% down from its last month's higher value of $1,959.00 and is 1.65% up from its last month's lower value of $1,827.80.

Volatility

Gold's last day, last week, and last month's average volatility was a positive 0.72%, a negative 0.61%, and a positive 0.38%, respectively.

Gold's last day, last week, and last month's high and low average amplitude percentage was 0.28%, 1.28%, and 0.57%, respectively.

Last news about Gold

New placer dome gold corp. drills 6.1 metres of 10.22 g/t gold, expanding gold mineralization at its kinsley project in Nevada. According to Business Insider on Monday, 11 January, "VANCOUVER, BC, Jan. 11, 2021 /CNW/ -New Placer Dome Gold Corp. ("New Placer Dome" or the "Company") (TSXV: NGLD) (OTCQB: NPDCF) (FSE: BM5) is pleased to report assay results for the initial nine reverse circulation ("RC") drill holes completed during 2020 at its flagship Kinsley Mountain Gold Project ("Kinsley Mountain") in mining friendly Nevada. ", "New Placer Dome's flagship Kinsley Mountain Gold Project, located 90 km south of the Long Canyon Mine (currently in production under the Newmont/Barrick Joint Venture), hosts Carlin-style gold mineralization, previous run of mine heap leach production, and NI 43-101 indicated resources containing 418,000 ounces of gold grading 2.63 g/t Au (4.95 million tonnes) and inferred resources containing 117,000 ounces of gold averaging 1.51 g/t Au (2.44 million tonnes)2. "

Gold price forecast: xau/usd grasps for support after bearish engulf. According to DailyFX on Monday, 11 January, "The bearish engulfing formation that printed last week brings on the prospect of fresh lows in Gold prices, with focus on the late-November swing around 1764.", "As the US Dollar continues to pullback, Gold prices have been offered aggressively over the past few trading days as the yellow metal has pushed down to a fresh monthly low."

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com